glp-1 receptor agonist and dpp-4 inhibitor combination not recommended do combine inhibitors with agonists guidance What classes of diabetes GLP-1 receptor agonist versus DPP-4

GLP-1 or GLP-1R agonists display a diverse range of physiological functions as shown in the image below

Common GLP-1 drugs include: Semaglutide (Ozempic, Wegovy, Rybelsus) Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) Exenatide (Byetta, Bydureon) These drugs improve insulin resistance , aid in weight loss , and now appear to reduce inflammation , offering benefits far beyond diabetes

No funding was received to assist with the preparation of this manuscript

doi: 10.1095/biolreprod.115.137539 164 SunZLiPWangXLaiSQiuHChenZet al

Retatrutide might not be appropriate for individuals who have specific medical issues or allergies

9,16 The weekly dosed agonists included semaglutide, which started at 0.25 mg and titrated up to 2.02.4 mg, and tirzepatide, which began at 2.5 mg and escalated up to 15 mg weekly